Arax Advisory Partners’s Nuveen AA-BBB CLO ETF NCLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$16.9M Buy
673,689
+200,682
+42% +$5.03M 0.1% 226
2026
Q2
$11.9M Buy
473,007
+112,052
+31% +$2.8M 0.08% 269
2026
Q1
$9M Buy
360,955
+219,472
+155% +$5.48M 0.25% 85
2025
Q4
$3.54M Sell
141,483
-2,244
-2% -$56.2K 0.1% 160
2025
Q3
$3.61M Buy
143,727
+72,537
+102% +$1.82M 0.05% 311
2025
Q2
$1.79M Buy
+71,190
New +$1.78M 0.08% 160

Other funds holding NCLO

Arax Advisory Partners's NCLO Position: Q3 2026 in Review

Arax Advisory Partners increased its Nuveen AA-BBB CLO ETF (NCLO) stake by 42% in Q3 2026, buying an estimated $5.03M and bringing the position to 673,689 shares worth $16.9M. The position accounts for 0.1% of the portfolio, ranked #226.

Arax Advisory Partners first reported a position in NCLO in Q2 2025 and has held it in 6 quarters since. 18 funds tracked by Wall St. Rank hold NCLO as of Q3 2026.

  • Arax Advisory Partners held 673,689 shares of Nuveen AA-BBB CLO ETF worth $16.9M as of Q3 2026.
  • Arax Advisory Partners bought 200,682 Nuveen AA-BBB CLO ETF shares in Q3 2026, an estimated $5.03M.
  • Nuveen AA-BBB CLO ETF made up 0.1% of Arax Advisory Partners's portfolio in Q3 2026, its #226 holding.
  • Arax Advisory Partners first reported a position in Nuveen AA-BBB CLO ETF in Q2 2025 and has held it in 6 quarters since.
  • 18 funds tracked by Wall St. Rank held Nuveen AA-BBB CLO ETF as of Q3 2026.

Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.